Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Feb;11(1):21-8.
doi: 10.1007/s12519-015-0003-9. Epub 2015 Jan 28.

Pathogenesis of childhood idiopathic nephrotic syndrome: a paradigm shift from T-cells to podocytes

Affiliations
Review

Pathogenesis of childhood idiopathic nephrotic syndrome: a paradigm shift from T-cells to podocytes

Kazunari Kaneko et al. World J Pediatr. 2015 Feb.

Abstract

Background: Nephrotic syndrome is the most common cause of kidney disease in children, but its pathogenesis remains unclear. This article reviews the novel aspects of the mechanisms underlying massive proteinuria in minimal-change disease, which is the most common form of childhood nephrotic syndrome.

Data sources: This article integrates the findings of a PubMed database search for English language articles published in the past 40 years (from September 1974 to February 2014) using the key words "pathogenesis", "minimal change nephrotic syndrome" or "idiopathic nephrotic syndrome".

Results: Unknown humoral factors associated with T-cell dysfunction have been thought to play an important role in the pathogenesis of minimal-change disease. However, recent findings are changing this paradigm, i.e., visceral glomerular epithelial cells (podocytes) may be involved via expression of molecules such as CD80 and angiopoietin-like 4.

Conclusions: Recent evidence suggests that minimal-change disease results from interactions between humoral factors and dysfunctional podocytes. In addition to immunosuppressant drugs that target lymphocytes, a biological agent such as an antibody against the abnormal molecule(s) expressed by podocytes may provide novel drug treatment for minimal-change disease.

PubMed Disclaimer

References

    1. Clin J Am Soc Nephrol. 2010 Nov;5(11):2115-21 - PubMed
    1. Nephrol Dial Transplant. 2003 Jan;18(1):70-6 - PubMed
    1. Sci Signal. 2010 May 18;3(122):ra39 - PubMed
    1. Pediatr Nephrol. 1994 Apr;8(2):135-9 - PubMed
    1. Nephrol Dial Transplant. 2012 Jan;27(1):81-9 - PubMed

Publication types

LinkOut - more resources